参考文献/References:
[1] Kagohashi K,Satoh H,Kurishima K,et al.Squamous cell carcinoma antigen in lung cancer and non-malignant respiratory diseases[J].Lung,2008,186(5):323-326.
[2] Oremex GM,Sauer-Eppel H,Bruzdziak TH.Value of tumor and inflammatorymarkers in lung cancer[J].Anticancer Research,2007,27(4A):1911-1915.
[3] Cho WC.Potentially useful biomarkers for the diagnosis,treatment and prognosis of lung cancer[J].Biomed Pharmacother,2007,61(9):515-519.
[4] 赵 肖, 王孟昭. 肺癌血清肿瘤标志物的临床意义[J].中国肺癌杂志,2011,14(3):286-291.
Zhao X,Wang MZ.Clinical utility of serum tumor markersof lung cancer[J].Chinese Journal of Lung Cancer,2011,14(3):286-291.
[5] 罗 杰, 冷卫东. 系统评价/Meta分析理论与实践[M].北京:军事医学科学出版社,2013:66.
Luo J,Leng WD.Theory and practice of systematic Review/Meta analysis[M].Beijing:Military Medical Science Press,2013:66.
[6] 伏春明,翁维明.3种肿瘤标志物联合检测在肺癌临床诊断中的价值[J].检验医学与临床,2013,10(19):2602-2603.
Fu CM,Weng WM.The clinical value of three kinds of tumor markers combined detection in lung cancer diagnosis[J].Laboratory Medicine and Clinic,2013,10(19):2602-2603.
[7] 姜晓明,陈 爽,杜晓艳,等.5种血清肿瘤标志物检测在肺癌诊断中的临床价值[J].吉林医药学院学报,2013,34(2):81-84.
Jiang XM,Chen S,Du XY,et al.Diagnosis value of five serum tumormarkers in lung cancer[J].Journal of Jilin Medical College,2013,34(2):81-84.
[8] 李 勇.6种肿瘤标志物联合检测在肺癌诊断中的价值评价[J].医学理论与实践,2013,26(19):2623-2624.
Li Y.The value assessment of the six kinds of tumor markers combined detection in lung cancer diagnosis[J].The Journal of Medical Theory and Practice,2013,26(19):2623-2624.
[9] 张 静,贾继敏.血清肿瘤标志物联合检测在肺癌诊断中的临床应用[J].中国基层医药,2013,20(18):2775-2776.
Zhang J,Jia JM.Clinical application of combined detection of serum tumor markers in diagnosis lung cancer[J].Chinese Journal of Primary Medicine and Pharmacy,2013,20(18):2775-2776.
[10] 谢海宝.CEA,CYFRA21-1,SCC和NSE联检对肺癌诊断的临床意义[J].放射免疫学杂志,2013,26(1):119-120.
Xie HB.The clinical significance of CEA,CYFRA 21-1,SCC and NSE combined detection in the lung cancer diagnosis[J].Journal of Radioimmunology,2013,26(1):119-120.
[11] 江 涛.比较5种血清肿瘤标志物联合检测对肺癌诊断和治疗的临床效果[J].中国医学创新,2014,11(3):62-64.
Jiang T.Comparison of kinds of serum tumor markers in the clinical effects of combined detection for the diagnosis and treatment of lung cancer[J].Medical Innovations of China,2014,11(3):62-64.
[12] 廖小莉,廖思娜,林 燕.多种血清肿瘤标志物联合检测在肺癌诊断的临床意义[J].医学信息,2012,25(4):113.
Liao XL,Liao SN,Lin Y.The clinical significance of multiple serum tumormarkers combined detection in lung cancer diagnosis[J].Medical Information,2012,25(4):113.
[13] 蓝永乐,李介华,梁大立,等.肺肿瘤三项标志物检测在肺癌诊断中的临床意义[J].中国现代医生,2013,51(9):91-92.
Lan YL,Li JH,Liang DL,et al.Clinical significance of three lung tumormarker tests in the diagnosis of lung cancer[J].China Modern Doctor,2013,51(9):91-92.
[14] 戴诗敏,梁世锋,谢少娟,等.联合检测5种血清肿瘤标志物在肺癌诊断中的意义[J].临床肺科杂志,2013,18(5):957-958.
Dai SM,Liang SF,Xie SJ,et al.The clinical value of five kinds of serumtumor markers combined detection for the lung cancer diagnosis[J].Journal ofClinical Pulmonary Medicine,2013,18(5):957-958.
[15] 曾 聪, 全国莉, 王春莲.联合检测6种血清肿瘤标志物在肺癌诊断中的意义[J].广东医学,2012,33(6):808-810.
Zeng C,Quan GL,Wang CL.The clinical value of six kinds of serum tumor markers combined Detection for the lung cancer diagnosis[J].Guangdong MedicalJournal,2012,33(6):808-810.
[16] 赵春明,崔诗晗,赵岩峰.联合检测CEA,CA125,N-SE,CYFRA21-1及SCC在肺癌诊断中的意义[J].标记免疫分析与临床,2013,20(5):353-355.
Zhao CM,Cui SH,Zhao YF.The significance of C-EA,CA125,NSE,CYFRA21-1 and SCC combined detection in lung cancer diagnosis[J].Labeled Immunoassaysand Clinical Medicine,2013,20(5):353-355.
[17] 潘 蔚.联合检测神经元特异性烯醇化酶和癌胚抗原在肺癌与肺结核鉴别诊断中的价值[J].实用心脑肺血管病杂志,2014,22(1):33-34.
Pan W.Differential diagnosis value of combined detection of neuron-specific enolase and carcinoembryonic antigen for lung cancer and pulmonary tuberculosis[J].Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease,2014,22(1):33-34.
[18] 刘 英,景 超.联合检测血清NSE,CEA和CYF-RA21-1对肺癌的诊断价值[J].成都医学院学报,2012,7(03Z):1-2.
Liu Y,Jing C.The value of detecting NSE,CEA and CYFRA21-1 for diagnosis of lung cancer[J].Journal of Chengdu Medical College,2012,7(03Z):1-2.
[19] 张锦华.联合检测血清肿瘤标志物在肺癌诊断中的应用价值分析[J].中国医学创新,2013,10(27):83-85.
Zhang JH.Analysis of the application values of joint detection with serumtumor markers in the diagnosis of lung cancer[J].Medical Innovations of China,2013,10(27):83-85.
[20] 张丽红.联检血浆D-D、血清CRP和四种肿瘤标志物对早期肺癌的诊断价值[J].放射免疫学杂志,2013,26(4):459-462.
Zhang LH.The value of combined detection of plasma DD,serum CRP and fourtumor markers in the diagnosis of the early lung cancer[J].Journal of Radioimmunoassay,2013,26(4):459-462.
[21] 张宏兴.探讨6种肿瘤标志物联合检测在肺癌诊断中的价值[J].中国实用医药,2013,8(1):73-74.
Zhang HX.Discussion on six kinds of tumor markers combined detection in the lung cancer diagnosis value[J].China Practical Medicine,2013,8(1):73-74.
[22] 方莉萍,邵丽佳,朱以军.血清CEA,SCC,NSE联检对诊断肺癌的临床价值[J].放射免疫学杂志,2013,26(6):846-847.
Fang LP,Shao LJ,Zhu YJ.Clinical value of serum CEA,SCC,NSE combined detection in the diagnosis of lung cancer[J].Journal of Radioimmunoassay,2013,26(6):846-847.
[23] 于海涛,刘秀娜.血清CEA联合CA125,CYFR21-1,NSE检测在肺癌诊断中的临床评价[J].临床医药实践,2014,23(1):26-28.
Yu HT,Liu XN.The clinical evaluation on serum CEA,CA125,CYFR21-1,NSEfor the diagnosis of lung cancer[J].Proceoding of Clinical Medicine,2014,23(1):26-28.
[24] 章岳峰,张 静,周伟鹤,等.血清C-反应蛋白和癌胚抗原水平在肺癌诊断中的价值[J].中华全科医学,2013,11(11):1692-1693.
Zhang YF,Zhang J,Zhou WH,et al.The clinical si-gnificance of serum C-reactive protein and CEA levels for the diagnosis of lung cancer[J].ChineseJournal of General Practice,2013,11(11):1692-1693.
[25] 江建蘋,王火强,廖桂东.血清NSE和CYFRA21-1联检在肺癌诊断中的价值[J].放射免疫学杂志,2013,26(6):744-745.
Jiang JP,Wang HQ,Liao GD.The value of serum NSE and CYFRA21-1 combineddetection in lung cancer diagnosis[J].Journal of Radioimmunoassay,2013,26(6):744-745.
[26] 宋福珍.血清铁蛋白及其他四种肿瘤标志物检测对肺癌的诊断作用[J].中国当代医药,2013,20(8):105-106.
Song FZ.Serum ferritin and other four kinds of tumor markers in the diagnosis of lung cancer detection function[J].China Modern Medicine,2013,20(8):105-106.
[27] 刘广军,谢宗涛.血清肿瘤标记物对非小细胞肺癌的诊断价值[J].河北医学,2012,18(3):297-300.
Liu GJ,Xie ZT.Diagnostic value of single and combined determination of serum TPS cyfra21-1 and Ferritin in patients with NSCLL[J].Hebei Medicine,2012,18(3):297-300.
[28] 付晓红,陈碧君,马 萍,等.血清肿瘤标记物联合检测诊断肺癌的价值[J].广东医学,2013,34(3):401-404.
Fu XH,Chen BJ,Ma P,et al.The value of serum tumor markers combined detection in lung cancer diagnosis[J].Guangdong Medicine,2013,34(3):401-404.
[29] 方东风,汪德明.血清肿瘤标志物单项及联合检测在肺癌诊断中的临床价值[J].实用癌症杂志,2012,27(4):366-368.
Fang DF,Wang DM.The clinical value of 6 serum tumor markers in lung cancer diagnosis[J].The Practical Journal of Cancer,2012,27(4):366-368.
[30] 王 永,吕高荣,宋苏娟.血清肿瘤标志物检测在肺癌诊断中价值[J].浙江临床医学,2013,15(7):952-954.
Wang Y,L(¨overu)GR,Song SJ.The value of serum tumor markers detection in the lung cancer diagnosis[J].Zhejiang Clinical Medicine Journal,2013,15(7):952-954.
[31] 晋家智.血清肿瘤标志物联合检测在肺癌诊断中的价值分析[J].中外医疗,2013,32(6):188-189.
Jin JZ.Analysis of the clinical value in serum tumor markers test for thelung cancer diagnosis[J].China Foreign Medical Treatment,2013,32(6):188-189.
[32] 叶 兵,邹莉莉,陆友国,等.血清肿瘤标志物联合检测在肺癌诊断中的临床价值[J].医学综述,2012,18(4):632-634.
Ye B,Zou LL,Lu YG,et al.Clinical value of combined detection with serum tumor markers in diagnosis of lung cancer[J].Medical Recapitulate,2012,18(4):632-634.
[33] 郭小林,张 宁.肿瘤标志物的联合检测在肺癌诊断中的临床价值[J].中国当代医药,2013,20(21):35-36.
Guo XL,Zhang N.Clinical value of combined detection of serum tumor markers in diagnosis of lung cancer[J].China Modern Medicine,2013,20(21):35-36.
[34] 龙卫国.肿瘤标志物检验在肺癌诊断中的临床价值探析[J].中国医药指南,2013,11(17):651-652.
Long WG.Analysis of the clinical value in tumor markers test for the lungcancer diagnosis[J].Guide of China Medicine,2013,11(17):651-652.
[35] 刘玉芬.肿瘤标志物联合检测对肺癌早期诊断及病理分型的意义[J].社区医学杂志,2012,10(13):6-8.
Liu YF.Significance of joint detection of tumor ma-rkers in the early diagnosis and pathological classification on lung cancer[J].Journal of Community Medicine,2012,10(13):6-8.
[36] Hu B,Tian XH,Sun J,et al.Evaluation of individual and combined applications of serum biomarkers for diagnosis of hepatocellular carcinoma:a meta-analysis[J].Int J Mol Sci,2013,14(12),23559-23580.
[37] Sarkaria IS,Stojadinovic A,Talbot SG,et al.Squamous cell carcinoma related oncogene is highly expressed in developing,normal,and adenomatous adrenaltissue but not in aggressive adrenocortical carcinomas[J].Surgery,2004,136(6):1122-1128.
[38] 刘延峰,杨栓盈,尚文丽,等.CYFRA21-1对早期非小细胞肺癌诊断价值的Meta分析[J].西安交通大学学报(医学版),2011,32(1):34-37.
Liu YF,Yang SY,Shang WL,et al.Meta-analysis on the diagnostic value of CYFRA21-1 in early non-small cell lung cancer[J].Journal of Xi'an Jiaotong University(Medical Sciences),2011,32(1):34-37.
[39] 田 刚,周明术,杭永伦,等.肿瘤标志物对肺癌诊断价值PLS-DA和ANN-MPL模型评估[J].中华肿瘤防治杂志,2014,21(5):380-383.
Tian G,Zhou MS,Hang YL,et al.PLS-DA and A-NN-MPL model to estimatethe diagnostic value of four serum tumor markers for lung cancer[J].Chinese Journal of Cancer Prevention and Treatment,2014,21(5):380-383.
[40] 杨金荣,韩东方,沈建英,等.血清肿瘤标志物联合检测对非小细胞肺癌诊断价值的探讨[J].中华肿瘤防治杂志,2010,17(14):1113-1115.
Yang JR,Han DF,Chen JY,et al.Diagnostic value of serum tumor markers in non-small cell lung cancer[J].Chinese Journal of Cancer Prevention and Treatment,2010,17(14):1113-1115.
[41] 王小杰,刘佳丽,许崇安.血清CYFRA21-1,CEA及NSE对非小细胞肺癌诊断价值的Meta分析[J].临床肿瘤学杂志,2011,16(12):1076-1079.
Wang XJ,Liu JL,Xu CA.Diagnostic value of serum CYFRA21-1,CEA and NSEin non-small cell lung cancer:A meta analysis[J].Chinese Clinical Oncology,2011,16(12):1076-1079.
相似文献/References:
[1]马丽颜,梁 静,周建龙.腺瘤样结肠息肉易感基因(APC)及结直肠癌缺失基因(DCC)基因甲基化在肺癌早期诊断的意义[J].现代检验医学杂志,2016,31(01):17.[doi:10.3969/j.issn.1671-7414.2016.01.005]
MA Li-yan,LIANG Jing,ZHOU Jian-long.Evaluation of the Combination of APC and DCC Gene Methylation
in the Early Diagnosis of Lung Cancer[J].Journal of Modern Laboratory Medicine,2016,31(01):17.[doi:10.3969/j.issn.1671-7414.2016.01.005]
[2]翟海军,朱晶.红细胞分布宽度对肺癌预后的临床分析[J].现代检验医学杂志,2015,30(06):147.[doi:10.3969/j.issn.1671-7414.2015.06.045]
ZHAI Hai-jun,ZHU Jing.Clinical Analysis of Red Blood Cell Distribution
Width on the Prognosis of Lung Cancer[J].Journal of Modern Laboratory Medicine,2015,30(01):147.[doi:10.3969/j.issn.1671-7414.2015.06.045]
[3]姜 波,王玉明,段 勇.肺癌组织中调控PUMA基因
的miRNA筛查和MiR-221表达差异研究[J].现代检验医学杂志,2015,30(01):15.[doi:10.3969/j.issn.1671-7414.2015.01.005]
JIANG Bo,WANG Yu-ming,DUAN Yong.Study on the Differential Expression of miRNA Screening and MiR-221
Regulates Apoptosis by Targeting PUMA Gene in Lung Cancer[J].Journal of Modern Laboratory Medicine,2015,30(01):15.[doi:10.3969/j.issn.1671-7414.2015.01.005]
[4]赵车冬,闫玉珠,吴文婧,等.血清CEA,CYFRA21-1,NSE水平在肺癌诊断与分型中的应用价值[J].现代检验医学杂志,2016,31(06):59.[doi:10.3969/j.issn.1671-7414.2016.06.016]
ZHAO Che-dong,YAN Yu-zhu,WU Wen-jing,et al.Application Value of Serum CEA,CYFRA21-1 and NSE Levels
in the Diagnosis and Typing of Lung Cancer[J].Journal of Modern Laboratory Medicine,2016,31(01):59.[doi:10.3969/j.issn.1671-7414.2016.06.016]
[5]王 冰,朱月蓉,何玉杰,等.血清结合珠蛋白在宫颈癌诊断中的应用研究[J].现代检验医学杂志,2017,32(01):106.[doi:10.3969/j.issn.1671-7414.2017.01.029]
WANG Bing,ZHU Yue-rong,HE Yu-jie,et al.Application of Haptoglobin in Cervical Cancer Diagnosis[J].Journal of Modern Laboratory Medicine,2017,32(01):106.[doi:10.3969/j.issn.1671-7414.2017.01.029]
[6]董 莉,张保平,冯新平,等.血浆HSP90α检测在肺癌诊断中的临床应用价值研究[J].现代检验医学杂志,2017,32(04):97.[doi:10.3969/j.issn.1671-7414.2017.04.027]
DONG Li,ZHANG Bao-ping,FENG Xin-ping,et al.Plasma HSP90 Alpha Testing Clinical Application Value
in the Diagnosis of Lung Cancer Researc[J].Journal of Modern Laboratory Medicine,2017,32(01):97.[doi:10.3969/j.issn.1671-7414.2017.04.027]
[7]朱文芳,沈建军,付 涛,等.血清GPDA联合肿瘤标志物对胃癌早期诊断的临床价值[J].现代检验医学杂志,2017,32(04):110.[doi:10.3969/j.issn.1671-7414.2017.04.031]
ZHU Wen-fang,SHEN Jian-jun,FU Tao,et al.Clinical Value of Serum GPDA Associated Tumor Markers
for Early Diagnosis of Gastric Cancer[J].Journal of Modern Laboratory Medicine,2017,32(01):110.[doi:10.3969/j.issn.1671-7414.2017.04.031]
[8]舒放,王海峰.电化学发光法检测胃泌素肽前体(ProGRP)影响因素分析[J].现代检验医学杂志,2018,33(06):140.[doi:10.3969/j.issn.1671-7414.2018.06.036]
SHU Fang,WANG Hai-feng.Analysis of Influence Factors of Detecting Pro-Gastrin-Releasing Peptide(ProGRP)by Electrochemiluminescence[J].Journal of Modern Laboratory Medicine,2018,33(01):140.[doi:10.3969/j.issn.1671-7414.2018.06.036]
[9]张利祥,潘 静,赵 洁,等.痰液基细胞学检查与血清CYFRA21-1,CEA,NSE联合检测对肺癌的诊断价值[J].现代检验医学杂志,2019,34(03):99.[doi:10.3969/j.issn.1671-7414.2019.03.024]
ZHANG Li-xiang,PAN Jing,ZHAO Jie,et al.Value of the Combined Determination of Sputum Liquid-Based Cytologyand Serum CYFRA21-1,CEA,NSE for the Diagnosis of Lung Cancer[J].Journal of Modern Laboratory Medicine,2019,34(01):99.[doi:10.3969/j.issn.1671-7414.2019.03.024]
[10]樊 华,弥 鹏,杨 波,等.肺癌患者外周血血小板参数检测分析及临床意义[J].现代检验医学杂志,2019,34(06):97.[doi:10.3969 ／ j.issn.1671-7414.2019.06.024]
FAN Hua,MI Peng,YANG Bo,et al.Analysis and Clinical Value of Peripheral Platelet Parameters
in Lung Cancer Patients[J].Journal of Modern Laboratory Medicine,2019,34(01):97.[doi:10.3969 ／ j.issn.1671-7414.2019.06.024]